Universitätsklinikum Freiburg

Hospital


Location: Freiburg, Germany (DE) DE

ISNI: 0000000094287911

ROR: https://ror.org/03vzbgh69

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Preferences, attitudes and views regarding genetic newborn screening (gNBS) for rare diseases: a systematic review of the literature and synthesis from 2009 to 2022 (2026) Martin S, Kyosovska-Peshtenska G, Audi J, Zarakowska K, Grauman Å, Veldwijk J, Hauber B, et al. Journal article, Review article Clinical and treatment-related predictors of complete response after total neoadjuvant therapy for rectal cancer in a large multicenter analysis (2026) Wurschi GW, Schneider M, Becker JN, Frerker B, Vorbach SM, Ehret F, Diefenhardt M, et al. Journal article A longitudinal bifactor approach to modelling somatic symptom development in psychosomatic treatment (2026) Petzke TM, Köteles F, Kessler H, Doering S, Kehyayan A, Pape M, Hofmann T, et al. Journal article Economic value of anti-CD20 therapies in multiple sclerosis: a systematic review of cost-effectiveness studies (2026) Heinemann J, Zirkel M, Schöffski O, Dersch R, Wiendl H Journal article, Review article Treatment patterns in geriatric patients with melanoma and the effect of age on the efficacy of immunotherapy: Analysis from the real-world multicenter registry ADOREG (2026) Lallas K, Nanz L, Ugurel S, Mohr P, Meier F, Weichenthal M, von Wasielewski I, et al. Journal article Loss-of-function variants in the CAPN1 activator CD99L2 cause X-linked spastic ataxia (2026) Menden B, Incebacak Eltemur RD, Demidov G, Sturm M, Park J, Huridou C, Fath F, et al. Journal article O-(2-[18F]fluoroethyl)-L-tyrosine-PET-guided versus contrast-enhanced T1-weighted MRI-guided re-irradiation in patients with recurrent glioblastoma (GLIAA/NOA-10 ARO2013-01): a multicentre, open-label, randomised trial (2026) Grosu AL, Weber WA, Graf E, Mix M, Nestle U, Schimek-Jasch T, Wiehle R, et al. Journal article COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant Melanoma (2026) Weichenthal M, Debus D, Zimmer L, Wasielewski Iv, Meier F, Tüting T, Heppt M, et al. Journal article Integrated immune profiling of chordomas reveals spatially organized niches and functional heterogeneity (2026) Arrieta VA, Benotmane JK, Du R, Habashy KJ, Zhao J, Najem H, Wang S, et al. Journal article Impact of comorbidities on treatment management and prognosis in patients with anaplastic thyroid cancer (ATC) (2026) Augustin T, Oliinyk D, Haderlein M, Frei C, Jacob J, Medenwald D, Trommer M, et al. Journal article